Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis

OBJECTIVES: The aim of this study was to examine the indirect burden of employed multiple sclerosis (MS) patients initiating disease-modifying therapies (DMTs) in the US. METHODS: DMT-treated MS patients (DMT users) and direct-matched controls without MS (1:3) were captured using the IBM MarketScan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonafede, Machaon, Mehta, Rina, Kim, Gilwan, Sruti, Ila, Tian, Marc, Pelletier, Corey, Goldfarb, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895882/
https://www.ncbi.nlm.nih.gov/pubmed/33051856
http://dx.doi.org/10.1007/s41669-020-00233-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895882/
https://www.ncbi.nlm.nih.gov/pubmed/33051856
http://dx.doi.org/10.1007/s41669-020-00233-8

Ejemplares similares